Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 91 to 105 of 320 results for antibiotics

  1. Antifungals to prevent fungal infection during antibiotic treatment for late-onset neonatal infection: What is the optimum regimen (including treatment duration and dose) for using antifungals to prevent secondary fungal infection associated with antibiotic treatment for late-onset neonatal infection?

    NG195/17 Question Antifungals to prevent fungal infection during antibiotic treatment for late-onset neonatal infection: What is the...

    Research recommendation
    Published
    6 August 2021

  2. Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)

    Summary of the evidence on eravacycline for complicated intra-abdominal infections in adults

    Evidence summary
    Published
    11 May 2022

  3. What is the clinical effectiveness of topical treatments (antibiotics and antiseptics) compared with oral antibiotics for the treatment of infected leg ulcer?

    clinical effectiveness of topical treatments (antibiotics and antiseptics) compared with oral antibiotics for the treatment...

    Research recommendation
    Published
    17 March 2020

  4. Preterm labour and birth (NG25)

    This guideline covers the care of women with a singleton pregnancy at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women with a singleton pregnancy having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.

    NICE guideline
    Last updated
    10 June 2022
    View recommendations

    Sections for NG25

  5. Early and late-onset meningitis: What is the optimal antibiotic treatment regimen for early-onset neonatal meningitis?

    Question Early and late-onset meningitis: What is the optimal antibiotic treatment regimen for early-onset neonatal meningitis? Any...

    Research recommendation
    Published
    6 August 2021

  6. What is the clinical and cost effectiveness of antibiotics for the management of acute diverticulitis in primary care?

    NG147/1 Question What is the clinical and cost effectiveness of antibiotics for the management of acute diverticulitis in primary care?...

    Research recommendation
    Published
    10 February 2020

  7. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NG15)

    This guideline covers the effective use of antimicrobials (including antibiotics) in children, young people and adults. It aims to change prescribing practice to help slow the emergence of antimicrobial resistance and ensure that antimicrobials remain an effective treatment for infection.

    NICE guideline
    Published
    18 August 2015
    View recommendations

    Sections for NG15

  8. Suspected sepsis: recognition, diagnosis and early management

    adults at emergency departments, to measure whether this approach reduces antibiotic prescriptions without increasing mortality. We will...

    NICE guideline
    In development

  9. What is the clinical and cost effectiveness of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis (SBP) in people with cirrhosis and ascites?

    NGO50/2 Question What is the clinical and cost effectiveness of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis...

    Research recommendation
    Published
    11 January 2024

  10. Intrapartum care (NG235)

    This guideline covers the care of women and their babies during labour and immediately after birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.

    NICE guideline
    Published
    29 September 2023
    View recommendations

    Sections for NG235

  11. Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most likely to benefit from prophylactic antibiotics?

    Recommendation ID NG115/5 Question Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who

    Research recommendation
    Published
    6 February 2019

  12. Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

    NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care

    Medtech innovation briefing
    Published
    14 September 2016

  13. QuikRead go for C-reactive protein testing in primary care (MIB78)

    NICE has developed a medtech innovation briefing (MIB) on the QuikRead go for C-reactive protein testing in primary care

    Medtech innovation briefing
    Published
    14 September 2016

  14. FebriDx for C-reactive protein and myxovirus resistance protein A testing (MIB224)

    NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing .

    Medtech innovation briefing
    Published
    26 August 2020

  15. Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised controlled trial should be undertaken to evaluate the clinical and cost effectiveness of stopping intravenous antibiotic therapy and switching to oral therapy within the first 24 hours of treatment in patients with neutropenic sepsis who are having treatment with intravenous antibiotics. The outcomes to be measured are overtreatment, death, need for critical care, length of hospital stay, duration of fever and quality of life.

    Question Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised...

    Research recommendation
    Published
    9 June 2015